| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028092699 |
| P356 | DOI | 10.1038/ICB.2014.60 |
| P698 | PubMed publication ID | 25047644 |
| P2093 | author name string | Nick Carpino | |
| Satya P Kunapuli | |||
| Alexander Y Tsygankov | |||
| Doina Ganea | |||
| Elisabetta Liverani | |||
| Elitza Ivanova | |||
| Fayez Safadi | |||
| Gian L Russo | |||
| Tiffanny N Newman | |||
| P2860 | cites work | Tyrosine 319 in the interdomain B of ZAP-70 is a binding site for the Src homology 2 domain of Lck | Q22009540 |
| A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R | Q24297906 | ||
| A novel histidine tyrosine phosphatase, TULA-2, associates with Syk and negatively regulates GPVI signaling in platelets | Q24336773 | ||
| Identification, cDNA cloning, and targeted deletion of p70, a novel, ubiquitously expressed SH3 domain-containing protein | Q24540267 | ||
| Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling | Q24625230 | ||
| Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo | Q24629443 | ||
| Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity | Q24642507 | ||
| A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3 | Q24644978 | ||
| A Phosphatase Activity of Sts-1 Contributes to the Suppression of TCR Signaling | Q27646954 | ||
| IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking | Q28208563 | ||
| c-Cbl facilitates fibronectin matrix production by v-Abl-transformed NIH3T3 cells via activation of small GTPases | Q28213787 | ||
| Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication | Q28265856 | ||
| Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells | Q28288275 | ||
| TULA-2, a novel histidine phosphatase, regulates bone remodeling by modulating osteoclast function | Q28586059 | ||
| Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2 | Q28587191 | ||
| Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells | Q28609046 | ||
| Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci | Q28943258 | ||
| Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes | Q29417127 | ||
| IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways | Q29614839 | ||
| Innate lymphoid cells--a proposal for uniform nomenclature | Q29617431 | ||
| Phenotypic and functional features of human Th17 cells | Q29619323 | ||
| Evidence of new risk genetic factor to systemic lupus erythematosus: the UBASH3A gene. | Q30009882 | ||
| Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases | Q30164059 | ||
| TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin | Q30164133 | ||
| Isolation and characterization of the UBASH3A gene on 21q22.3 encoding a potential nuclear protein with a novel combination of domains | Q30168322 | ||
| Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile | Q33301251 | ||
| Determination of the Substrate Specificity of Protein-tyrosine Phosphatase TULA-2 and Identification of Syk as a TULA-2 Substrate | Q33645197 | ||
| An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation | Q33876035 | ||
| Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-gamma1 and Ras activation | Q33890664 | ||
| Porphyromonas gingivalis gingipain-R enhances interleukin-8 but decreases gamma interferon-inducible protein 10 production by human gingival fibroblasts in response to T-cell contact | Q34008299 | ||
| Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis | Q43232770 | ||
| T-cell regulation of neutrophil infiltrate at the early stages of a murine colitis model | Q43284324 | ||
| Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. | Q43568780 | ||
| Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses | Q44081504 | ||
| Importance of innate immunity and collagen binding integrin alpha1beta1 in TNBS-induced colitis | Q44247183 | ||
| Galectin-1 suppresses experimental colitis in mice | Q44429812 | ||
| Analysis of the T cell receptor V beta repertoire in 2,4,6-trinitrobenzenesulfonic acid induced colitis in mice | Q44508604 | ||
| Intracellular Phospho-Flow cytometry reveals novel insights into TCR proximal signaling events. A comparison with Western blot | Q44540296 | ||
| Therapeutic effect of the immunomodulator glatiramer acetate on trinitrobenzene sulfonic acid-induced experimental colitis | Q45242443 | ||
| The presentation of haptenated proteins and activation of T cells in the mesenteric lymph nodes by dendritic cells in the TNBS colitis rat. | Q45245012 | ||
| All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. | Q45991876 | ||
| IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells | Q46043684 | ||
| RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. | Q46257713 | ||
| Detrimental role for CD4+ T lymphocytes in murine diffuse peritonitis due to inhibition of local bacterial elimination | Q46927831 | ||
| Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. | Q47777664 | ||
| Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis. | Q51825944 | ||
| FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis. | Q51983634 | ||
| Naturally arising CD4+CD25+ regulatory T cells suppress the expansion of colitogenic CD4+CD44highCD62L- effector memory T cells. | Q51986019 | ||
| Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. | Q54074094 | ||
| IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo. | Q54388635 | ||
| Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. | Q54471973 | ||
| Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice | Q59276550 | ||
| CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients | Q61885691 | ||
| Preincubation with anti-CD4 influences activation of human T cells by subsequent co-cross-linking of CD4 with CD3 | Q63859664 | ||
| Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice | Q73098249 | ||
| Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis | Q74303616 | ||
| Tyrosine 319, a newly identified phosphorylation site of ZAP-70, plays a critical role in T cell antigen receptor signaling | Q74485131 | ||
| The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis | Q80428039 | ||
| Mouse models of inflammatory bowel disease | Q81158539 | ||
| Critical role of IL-17 receptor signaling in acute TNBS-induced colitis | Q83276931 | ||
| Translating inflammatory bowel disease research into clinical medicine | Q84573739 | ||
| Protective CD8 memory T cell responses to mouse melanoma are generated in the absence of CD4 T cell help | Q34064488 | ||
| Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production | Q34098863 | ||
| Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases | Q34181228 | ||
| Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells | Q34299001 | ||
| Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. | Q34321127 | ||
| Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice | Q34321778 | ||
| IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 | Q34521302 | ||
| Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis | Q34575334 | ||
| T-cell ubiquitin ligand affects cell death through a functional interaction with apoptosis-inducing factor, a key factor of caspase-independent apoptosis | Q34665121 | ||
| TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology | Q34712326 | ||
| Effect of a CD4-depleting antibody on the development of Cryptococcus neoformans-induced allergic bronchopulmonary mycosis in mice | Q34721178 | ||
| Sts-2 is a phosphatase that negatively regulates zeta-associated protein (ZAP)-70 and T cell receptor signaling pathways | Q34963266 | ||
| Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study | Q34980995 | ||
| Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. | Q36229731 | ||
| Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. | Q36362779 | ||
| Antibodies to interleukin 12 abrogate established experimental colitis in mice | Q36365464 | ||
| Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance | Q36809886 | ||
| Induction and regulation of inflammatory bowel disease in immunodeficient mice by distinct CD4+ T-cell subsets. | Q36944574 | ||
| The histidine phosphatase superfamily: structure and function | Q37037661 | ||
| Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis | Q37098695 | ||
| Multidomain STS/TULA proteins are novel cellular regulators | Q37111363 | ||
| Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells | Q37242180 | ||
| The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. | Q37280352 | ||
| IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism | Q37325464 | ||
| Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. | Q37448373 | ||
| TULA-family proteins: an odd couple | Q37544376 | ||
| Intestinal effector T cells in health and disease. | Q37600191 | ||
| Regulatory T cells reinforce intestinal homeostasis | Q37600194 | ||
| Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease | Q37633430 | ||
| TULA-family proteins: a new class of cellular regulators | Q38017998 | ||
| Innate lymphoid cells--how did we miss them? | Q38071916 | ||
| Tip, an Lck-interacting protein of Herpesvirus saimiri, causes Fas- and Lck-dependent apoptosis of T lymphocytes | Q40579458 | ||
| Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease | Q41858578 | ||
| Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. | Q41904687 | ||
| Interleukin-23 drives intestinal inflammation through direct activity on T cells | Q42083897 | ||
| Chemically induced mouse models of intestinal inflammation | Q42510602 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 837-850 | |
| P577 | publication date | 2014-07-22 | |
| P1433 | published in | Immunology & Cell Biology | Q13731918 |
| P1476 | title | Members of the novel UBASH3/STS/TULA family of cellular regulators suppress T-cell-driven inflammatory responses in vivo | |
| P478 | volume | 92 |
| Q55510136 | Altered thymic differentiation and modulation of arthritis by invariant NKT cells expressing mutant ZAP70. |
| Q33427174 | Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice |
| Q64360608 | Discovery and Characterization of Two Classes of Selective Inhibitors of the Suppressor of the TCR Signaling Family of Proteins |
| Q39178438 | Genetics of primary sclerosing cholangitis and pathophysiological implications |
| Q90006694 | Identification of Candidate Risk Factor Genes for Human Idelalisib Toxicity Using a Collaborative Cross Approach |
| Q64991646 | Phagocytes from Mice Lacking the Sts Phosphatases Have an Enhanced Antifungal Response to Candida albicans. |
| Q93092263 | TULA-2 Deficiency Enhances Platelet Functional Responses to CLEC-2 Agonists |
| Q28854385 | TULA-2 Protein Phosphatase Suppresses Activation of Syk through the GPVI Platelet Receptor for Collagen by Dephosphorylating Tyr(P)346, a Regulatory Site of Syk |
| Q48290135 | UBASH3A Mediates Risk for Type 1 Diabetes Through Inhibition of T-Cell Receptor-Induced NF-κB Signaling |
| Q97643346 | UBASH3A deficiency accelerates type 1 diabetes development and enhances salivary gland inflammation in NOD mice |
Search more.